SVRA ▼ -20.2% - Savara Inc.
$SVRA Savara Informed That FDA Will Not Take Action on the Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) by the PDUFA Date
20-NOV-2026 08:30 AM ET
Share this post
More filings for $SVRA
SVRA - Savara Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026SVRA ▲ +0.6% - Savara Inc.Oct 21, 2026SVRA ▼ -1.8% - Savara Inc.Oct 12, 2026SVRA - Savara Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $SVRA filing history →💬 Comments
Loading comments…
Leave a comment
